Global 3D Bioprinting Market, By Component (3D Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices, Other Biomaterials), Application (Research Applications, Clinical Application), End User (Research Organization and Academic Institutes, Biopharmaceuticals Companies, Hospital), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The 3D bioprinting market is expected to witness market growth at a rate of 18.1% in the forecast period of 2021 to 2028 and is expected to reach USD 2,856.76 million by 2028. Data Bridge Market Research report on 3D bioprinting market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the investment is escalating the growth of 3D bioprinting market.
3D bioprinting refers to a specialized application of 3D printing that deals with the printing or development of bio-based materials such as organs, cells, tissues and extracellular matrix. These are used in several clinical and research applications. These modified medical products can imitate the natural tissues/organs, but they cannot be employed as replacement for the original organs.
The rise in the usage of 3D bioprinting in the pharmaceutical and cosmetology sectors acts as one of the major factors driving the growth of 3D bioprinting market. The surge in public and private funding to support bioprinting research activities and continuous technological advancements in the 3D bioprinting industry accelerate the 3D bioprinting market growth. The limited number of organ donors along with demand for organ transplants and increasing incidence of chronic diseases further influence the 3D bioprinting market. Additionally, rise in research and development activities, growth in awareness of 3D bioprinting, growing geriatric population, acceptance of advanced technologies and increase in healthcare expenditure positively affect the 3D bioprinting market. Furthermore, rise in demand for regenerative medicine and stem cell research extend profitable opportunity to the 3D bioprinting market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the 3D bioprinting and lacks of regulatory guidelines governing 3D bioprinting are the factors expected to obstruct the 3D bioprinting market growth. The rise in socioethical concerns related to the use of 3D bioprinted products is projected to challenge the 3D bioprinting market in the forecast period of 2021-2028.
This 3D bioprinting market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on 3D bioprinting market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
3D Bioprinting Market Scope and Market Size
The 3D bioprinting market is segmented on the basis of component, material, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of component, the 3D bioprinting market is segmented into 3D bioprinters and bioinks.
- On the basis of material, the 3D bioprinting market is segmented into living cells, hydrogels, extracellular matrices and other biomaterials.
- On the basis of application, the 3D bioprinting market is segmented into research applications and clinical application.
- On the basis of end user, the 3D bioprinting market is segmented into research organization and academic institutes, biopharmaceuticals companies and hospital.
Global 3D Bioprinting Market Country Level Analysis
The 3D bioprinting market is analyzed and market size insights and trends are provided by country, component, material, application and end user as referenced above.
The countries covered in the global 3D bioprinting market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the 3D bioprinting market due to the incorporation of IT in the healthcare industry and rise in spending by government on research and development in the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021-2028 due to the increasing the mortality rate due to COVID-19 and the shortage of organ donors in the region.
The country section of the 3D bioprinting market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The 3D bioprinting market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for 3D bioprinting market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on 3D bioprinting market. The data is available for historic period 2011-2019.
Competitive Landscape and 3D Bioprinting Market Share Analysis
The 3D bioprinting market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to 3D bioprinting market.
The major players covered in the 3D bioprinting market report are Advanced Solutions Life Sciences, LLC, Allevi, Inc., Digilab Inc, Nano3D Biosciences, Inc., Regenovo, ROKIT HEALTHCARE, TeVido BioDevices, 3Dynamic Systems Ltd, Cyfuse Biomedical K.K., ORGANOVO HOLDINGS, INC., CELLINK, Voxeljet, EnvisionTEC, GeSiM, Stratasys Ltd., Nano3D Biosciences, Inc., Poietis, regenHU, Biogelx, Aspect Biosystems Ltd., 3D Systems, Inc., Materialise and Solidscape Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.